臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 2853504
	???header.visitor??? : 45186390 ???header.onlineuser??? : 827 ???header.sponsordeclaration???

???search.scope???

???search.advance???

???search.login???

???search.administrator???

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wong g l h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-10 of 24 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-09-14T01:29:27Z	Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment	Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F.
臺大學術典藏	2022-09-09T04:21:24Z	Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine	Park J.; Le A.K.; Tseng T.-C.; Yeh M.-L.; Jun D.W.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung K.S.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H.
臺大學術典藏	2022-02-23T02:12:22Z	Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment	Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F.
臺大學術典藏	2022-02-23T02:12:18Z	Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B	Hsu Y.-C.; Yeh M.-L.; Wong G.L.-H.; CHIEN-HUNG CHEN; Peng C.-Y.; Buti M.; Enomoto M.; Xie Q.; Trinh H.; Preda C.; Liu L.; Cheung K.-S.; Yeo Y.H.; Hoang J.; Huang C.-F.; Riveiro-Barciela M.; Kozuka R.; Istratescu D.; Tsai P.-C.; Accarino E.V.; Lee D.-H.; Wu J.-L.; Huang J.F.; Dai C.-Y.; Cheung R.; Chuang W.-L.; Yuen M.-F.; Wong V.W.-S.; Yu M.-L.; Nguyen M.H.
臺大學術典藏	2022-02-22T05:34:11Z	Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment	Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F.
臺大學術典藏	2022-02-22T05:34:08Z	Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B	Hsu Y.-C.; Yeh M.-L.; Wong G.L.-H.; CHIEN-HUNG CHEN; Peng C.-Y.; Buti M.; Enomoto M.; Xie Q.; Trinh H.; Preda C.; Liu L.; Cheung K.-S.; Yeo Y.H.; Hoang J.; Huang C.-F.; Riveiro-Barciela M.; Kozuka R.; Istratescu D.; Tsai P.-C.; Accarino E.V.; Lee D.-H.; Wu J.-L.; Huang J.F.; Dai C.-Y.; Cheung R.; Chuang W.-L.; Yuen M.-F.; Wong V.W.-S.; Yu M.-L.; Nguyen M.H.
臺大學術典藏	2022-01-24T09:31:44Z	Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study	Dai C.-Y.; Tseng T.-C.; Wong G.L.H.; Huang J-F.; Wong V.W.S.; CHUN-JEN LIU; Yu M.-L.; Chuang W.-L.; Kao J.-H.; Yuen Chan H.L.; Chen D.-S.
臺大學術典藏	2022-01-24T09:31:22Z	Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment	Wong V.W.-S.; Chan W.-K.; Chitturi S.; Chawla Y.; Dan Y.Y.; Duseja A.; Fan J.; Goh K.-L.; Hamaguchi M.; Hashimoto E.; Kim S.U.; Lesmana L.A.; Lin Y.-C.; CHUN-JEN LIU; Ni Y.-H.; Sollano J.; Wong S.K.-H.; Wong G.L.-H.; Chan H.L.-Y.; Farrell G.
臺大學術典藏	2022-01-24T09:31:22Z	The Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups	Chitturi S.; Wong V.W.-S.; Chan W.-K.; Wong G.L.-H.; Wong S.K.-H.; Sollano J.; Ni Y.-H.; CHUN-JEN LIU; Lin Y.-C.; Lesmana L.A.; Kim S.U.; Hashimoto E.; Hamaguchi M.; Goh K.-L.; Fan J.; Duseja A.; Dan Y.Y.; Chawla Y.; Farrell G.; Chan H.L.-Y.
臺大學術典藏	2021-09-04T06:12:16Z	Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy	Lui Y.Y.-N.; Tsoi K.K.-F.; Wong V.W.-S.; JIA-HORNG KAO; Hou J.-L.; Teo E.-K.; Mohamed R.; Piratvisuth T.; Han K.-H.; Mihm U.; Wong G.L.-H.; Chan H.L.-Y.

Showing items 1-10 of 24 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page